Balchem Corporation (BCPC)
Balchem Corporation (BCPC) Q1 2026 Earnings Call Transcript
Balchem Corporation (BCPC) Q1 2026 Earnings Call Transcript
Conestoga Capital SMid Cap Composite Q1 2026 Portfolio Holdings
The Conestoga SMid Cap Composite returned -10.24% net-of-fees in the first quarter, lagging the Russell 2500 Growth Index's return of -3.52%. RBC's performance was driven by continued strength in aerospace and defense, where demand remains robust and increasingly visible through a growing backlog. Despite a solid quarter, Repligen stock underperformed as investors focused on a more measured outlook and lingering concerns around end-market demand.
Balchem: An Attractive Valuation Makes This Stock A Buy
Balchem delivered strong Q4 results, with revenue up nearly 10% year-over-year and all segments posting growth. BCPC boasts a 17-year streak of double-digit dividend hikes, supported by a payout ratio consistently below 20%. The stock trades at a roughly 25% discount to its estimated fair value, with robust forward return potential exceeding 14%.
Balchem Corporation (BCPC) Q4 2025 Earnings Call Transcript
Balchem Corporation (BCPC) Q4 2025 Earnings Call Transcript
Balchem: Bullish On Q3 Outperformance And Favorable Outlook (Upgrade)
I raise my rating for Balchem from "Hold" to "Buy," following my assessment of its performance and prospects. BCPC's 3Q2025 financials exceeded expectations, thanks to the strong showing from its Human Nutrition and Specialty Products segments. I'm anticipating that Balchem can realize growth acceleration in the mid-term by capitalizing on emerging food trends, a new production plant, and promising regulatory developments.
Balchem (BCPC) Q3 Earnings Lag Estimates (Revised)
Balchem (BCPC) came out with quarterly earnings of $1.35 per share, missing the Zacks Consensus Estimate of $1.36 per share. This compares to earnings of $1.03 per share a year ago.
Balchem (BCPC) Surpasses Q2 Earnings and Revenue Estimates (Revised)
Balchem (BCPC) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus Estimate of $1.25 per share. This compares to earnings of $0.98 per share a year ago.
Balchem Corporation (BCPC) Q2 2025 Earnings Call Transcript
Balchem Corporation (NASDAQ:BCPC ) Q2 2025 Earnings Conference Call July 31, 2025 11:00 AM ET Company Participants Carl Martin Bengtsson - Executive VP, CFO, Treasurer and GM of Animal Nutrition & Health Theodore Lee Harris - CEO, President & Chairman Conference Call Participants Anthony Polak - Unidentified Company Aegis Capital Corp. - Unidentified Company Daniel Scott Harriman - Sidoti & Company, LLC Raghuram Selvaraju - H.C. Wainwright & Co, LLC, Research Division Robert James Labick - CJS Securities, Inc. Operator Ladies and gentlemen, thank you for standing by.
Blachem (BCPC) Surpasses Q2 Earnings and Revenue Estimates
Blachem (BCPC) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus Estimate of $1.25 per share. This compares to earnings of $0.98 per share a year ago.
Balchem Corporation: The Next Earnings Release Should Guide Investors
Balchem operates in diverse specialty ingredient markets, maintaining steady growth and a market cap of $5.3B. Revenue per share has grown 6% annually over a decade, but recent growth has plateaued, warranting close monitoring. Gross profit margin has improved significantly, rising from 30% to over 35% in the latest fiscal year.
Balchem Corporation (BCPC) Q1 2025 Earnings Call Transcript
Balchem Corporation (NASDAQ:BCPC ) Q1 2025 Earnings Conference Call April 24, 2025 11:00 AM ET Company Participants Martin Bengtsson - CFO Ted Harris - Chairman, President & CEO Conference Call Participants Ram Selvaraju - H.C. Wainwright & Co Daniel Harriman - Sidoti & Company Operator Greetings, and welcome to Balchem's First Quarter 2025 Earnings Conference Call.
Blachem (BCPC) Lags Q1 Earnings Estimates
Blachem (BCPC) came out with quarterly earnings of $1.22 per share, missing the Zacks Consensus Estimate of $1.25 per share. This compares to earnings of $0.89 per share a year ago.
